Journal profile

Blood

Publisher: Elsevier
ISSN0006-4971 | 1528-0020 FormatPrint StatusCurrently indexed
Official Website Verify CrossRef

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
3.30
Citation rate 1.41 23,401 total citations
h5-index 147 h5 depth signal
Cited share 34.8% 5,939 of 17,075
Total citations 23,401 Citation footprint
Metric signal 1.46 External metric anchor
Self-citation 3.7% 863 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 39,050
China 7,272
Germany 6,218
United Kingdom 5,845
Italy 5,567

Citing Fields of Research

Hematology 44,432
Lymphomas 21,311
Immunology 11,339
Oncology 4,067
Stem Cell Biology 2,135

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 193,098 Articles tracked across the journal lifetime
Indexed publication set 17,075 5,939 cited publications
Last 12 months 9,312 776.0 publications/month
Open access share 3.3% 305 OA publications in the last year
Leading citing country United States 39,050 citing publications
Leading citing field Hematology 44,432 citing publications
Latest tracked publication 4 November 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v26n4, Oct. 1965-
PubMed
v26n4, Oct. 1965-
OLDMEDLINE
Active Coverage
Abridged index medicus
Active Coverage
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Hematology Lymphomas

Issuing & Sponsoring Bodies

Contributor
American Society of Hematology

Broad Categories

Hematology Lymphomas

MeSH Descriptors

Hematology

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

02
Open DOI
Shelley E Crary, Divyaswathi Citla-Sridhar, C D'ANn Pierce et al.
Gene therapy for hemophilia A (HA) aims to provide durable hemostatic control and reduce treatment burden, but AAV-based products to date have limitations: inconsistent peak expression, declining factor levels, and immunogenicity causing...
03
Open DOI
Eduardo Rodríguez-Arbolí, Elena Soria-Saldise, Eva Barragan et al.
RAS mutations are recurrent in acute myeloid leukemia (AML); yet, their genomic and clinical landscape remain poorly characterized. We analyzed centralized molecular profiling data in 8,553 patients with newly diagnosed AML. Of these, 1,...

Bibliographical & Catalog Notes

Journal of the American Society of Hematology, 1976-

Supplements accompany some vols.

Also issued online.

Microfilm. v. 1 (1946)-20 (1962). 32 microfilm reels : negative ; 35 mm.

Summaries in English, with some also in Interlingua.

Vol. 85, no. 6 (MAR15 1995)19950520 Notice not published Printed on acid-free paper